DocsApp, which has over 6 million users, also allows individuals to order medicines and book diagnostic tests online.
Venture debt firm InnoVen Capital has invested Rs 12 crore in online doctor consultation startup DocsApp.
"DocsApp's constant focus on bridging the existing gaps in India’s healthcare sector has led the company to gain a massive scale in the country. Its solutions have had a positive impact on people from Tier 1, 2 3, cities and also to those that do not have access to quality healthcare. As a result of its targeted solutions and exceptional metrics, it has achieved a leadership position in the market," said Punit Shah, director, InnoVen Capital India.
DocsApp was launched in 2015, with an aim to help patients across India connect and talk to specialist doctors, for high-quality consultations over video calls, voice calls and an in-built chat application.
The platform, which has over 6 million users, also allows individuals to order medicines and book diagnostic tests online.
The company claims to have over 5,000 specialist doctors registered on its AI-powered platform. It provides consultation across 15 specialties including dermatology, gynaecology, sexology, paediatrics, psychiatry, general medicine and weight management, among others.
A growing population, rising prevalence of chronic diseases, the dearth of healthcare professionals worldwide, improvements in telecommunication infrastructure, and need for affordable treatment options due to rising healthcare costs are some of the factors expected to propel the growth of telemedicine market in the coming years.
The company last raised $7.2 million in Series A funding from Bessemer Venture Partners and Japanese investment firms Techmatrix Corporation and DeNa Networks.
DocsApp competes with firms such as Lybrate, JustDoc, DoctorInsta, among others.
To get profitable financial guidance, give one missed call on 9644405057. We offer 2 days of free trial. Our packages are affordable. Click here to visit our website: Best Stock Option Tips
No comments:
Post a Comment